Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

29 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The burden of diabetes and impaired fasting glucose in India using the ADA 1997 criteria: prevalence of diabetes in India study (PODIS).
Sadikot SM, Nigam A, Das S, Bajaj S, Zargar AH, Prasannakumar KM, Sosale A, Munichoodappa C, Seshiah V, Singh SK, Jamal A, Sai K, Sadasivrao Y, Murthy SS, Hazra DK, Jain S, Mukherjee S, Bandyopadhay S, Sinha NK, Mishra R, Dora M, Jena B, Patra P, Goenka K; DiabetesIndia. Sadikot SM, et al. Diabetes Res Clin Pract. 2004 Dec;66(3):293-300. doi: 10.1016/j.diabres.2004.04.007. Diabetes Res Clin Pract. 2004. PMID: 15536027
Comparing the ADA 1997 and the WHO 1999 criteria: Prevalence of Diabetes in India Study.
Sadikot SM, Nigam A, Das S, Bajaj S, Zargar AH, Prasannakumar KM, Sosale A, Munichoodappa C, Seshiah V, Singh SK, Jamal A, Sai K, Sadasivrao Y, Murthy SS, Hazra DK, Jain S, Mukherjee S, Bandyopadhay S, Sinha NK, Mishra R, Dora M, Jena B, Patra P, Goenka K; DiabetesIndia. Sadikot SM, et al. Diabetes Res Clin Pract. 2004 Dec;66(3):309-15. doi: 10.1016/j.diabres.2004.04.009. Diabetes Res Clin Pract. 2004. PMID: 15536028
The burden of diabetes and impaired glucose tolerance in India using the WHO 1999 criteria: prevalence of diabetes in India study (PODIS).
Sadikot SM, Nigam A, Das S, Bajaj S, Zargar AH, Prasannakumar KM, Sosale A, Munichoodappa C, Seshiah V, Singh SK, Jamal A, Sai K, Sadasivrao Y, Murthy SS, Hazra DK, Jain S, Mukherjee S, Bandyopadhay S, Sinha NK, Mishra R, Dora M, Jena B, Patra P, Goenka K; DiabetesIndia. Sadikot SM, et al. Diabetes Res Clin Pract. 2004 Dec;66(3):301-7. doi: 10.1016/j.diabres.2004.04.008. Diabetes Res Clin Pract. 2004. PMID: 15609460
Consensus statement on diabetes in children.
Prasanna Kumar KM, Dev NP, Raman KV, Desai R, Prasadini TG, Das AK, Ramoul S. Prasanna Kumar KM, et al. Indian J Endocrinol Metab. 2014 May;18(3):264-73. doi: 10.4103/2230-8210.129714. Indian J Endocrinol Metab. 2014. PMID: 24944917 Free PMC article. Review.
Efficacy and safety of exenatide once weekly versus metformin, pioglitazone, and sitagliptin used as monotherapy in drug-naive patients with type 2 diabetes (DURATION-4): a 26-week double-blind study.
Russell-Jones D, Cuddihy RM, Hanefeld M, Kumar A, González JG, Chan M, Wolka AM, Boardman MK; DURATION-4 Study Group. Russell-Jones D, et al. Diabetes Care. 2012 Feb;35(2):252-8. doi: 10.2337/dc11-1107. Epub 2011 Dec 30. Diabetes Care. 2012. PMID: 22210563 Free PMC article. Clinical Trial.
National recommendations: Psychosocial management of diabetes in India.
Kalra S, Sridhar GR, Balhara YP, Sahay RK, Bantwal G, Baruah MP, John M, Unnikrishnan AG, Madhu K, Verma K, Sreedevi A, Shukla R, Prasanna Kumar KM. Kalra S, et al. Among authors: prasanna kumar km. Indian J Endocrinol Metab. 2013 May;17(3):376-95. doi: 10.4103/2230-8210.111608. Indian J Endocrinol Metab. 2013. PMID: 23869293 Free PMC article.
29 results